Head & Neck Cancer: UK Inequalities Linked to Deprivation & Postcode

New analysis reveals stark inequalities in head and neck cancer outcomes across the UK, with those living in the most socioeconomically deprived areas facing a significantly higher risk of death and later-stage diagnosis. The report, released today by the Northern Head and Neck Alliance (NHNA) and Health Equity North, highlights a particularly concerning trend in northern England and Scotland, where rates of both new cases and deaths from these cancers are among the highest in the country.

Head and neck cancers encompass a range of malignancies affecting the mouth, tongue, throat, voice box, and salivary glands. These cancers can profoundly impact quality of life, affecting speech, swallowing, and even appearance. Currently, nearly 13,000 people are diagnosed with head and neck cancer annually in the UK, resulting in approximately 5,000 deaths each year – numbers projected to rise to over 16,000 new cases by the 2030s. The findings underscore a critical necessitate for targeted interventions to address these disparities.

Socioeconomic Divide in Cancer Outcomes

The analysis demonstrates a clear link between socioeconomic status and head and neck cancer outcomes. Individuals in the most deprived areas are nearly 2.5 times more likely to die from these cancers compared to those in the least deprived areas. This disparity extends to the stage at which cancer is diagnosed, with those from poorer backgrounds 16% more likely to receive a diagnosis at an advanced stage. They face longer waits for treatment, with a 33% increased likelihood of waiting over 104 days for care to begin.

The geographical impact is too pronounced. All seven Integrated Care Boards (ICBs) in northern England exhibit higher rates of head and neck cancer than the England average. Six of these ICBs also report higher death rates, with the North East and North Cumbria experiencing the most severe outcomes. Scotland’s rates are even higher than those seen in the North of England. Health Equity North, a virtual institute focused on addressing public health problems and health inequalities, played a key role in this research.

HPV Vaccination and Dental Referrals: Points of Intervention

The report also sheds light on preventative measures and early detection. Uptake of the Human Papillomavirus (HPV) vaccine – a crucial tool in preventing certain types of head and neck cancer – is 21% lower in the most socioeconomically deprived areas. Simultaneously, individuals in these areas are less likely to be referred to a dentist when experiencing early symptoms, despite dental referrals being a vital component of early detection. This suggests that access to preventative care and timely referrals are significantly influenced by socioeconomic factors.

Understanding the Data: Methods and Limitations

The NHNA research team, comprised of experts from universities across the North of England and Scotland – including the University of Liverpool, Newcastle University, and the University of Glasgow – analyzed existing data to map socioeconomic inequalities in head and neck cancer. While the analysis provides compelling evidence of disparities, it’s important to acknowledge the limitations inherent in using existing datasets. The study relies on observational data, meaning it can demonstrate associations but cannot definitively prove causation. Further research is needed to fully understand the complex interplay of factors contributing to these inequalities.

The Role of Integrated Care Systems

Integrated Care Systems (ICSs) were introduced in England in 2022 to bring together organizations that deliver and plan health and care services. The fact that all seven northern ICBs have higher rates of head and neck cancer than the England average suggests that current strategies may not be effectively addressing the specific needs of these regions. The NHNA report calls for closer monitoring of waiting-time inequalities within ICBs and for services to be designed in partnership with local communities to ensure they are culturally sensitive, and accessible.

Waiting Times and Access to Treatment

The report highlights significant concerns regarding waiting times for head and neck cancer treatment in England. Almost 50% of patients do not begin treatment within the NHS’s 62-day target. This delay can have a profound impact on outcomes, potentially allowing the cancer to progress and reducing the effectiveness of treatment. Addressing these waiting times is a critical priority, particularly for those in the most deprived areas who are disproportionately affected.

What’s Next: Recommendations and Future Research

Professor Terry Jones, Chair of the Northern Head and Neck Alliance and Professor of Head and Neck Surgery at the University of Liverpool, emphasized the urgency of the situation: “No cancer should be more deadly because of the community you come from. Fixing that failure would improve care for every patient.” The NHNA’s recommendations focus on a multi-pronged approach, encompassing public health initiatives, improvements to NHS services, and increased research investment.

Key priorities include expanding stop-smoking and alcohol-reduction support in disadvantaged communities, strengthening tobacco control measures, and increasing HPV vaccination uptake in schools serving deprived populations. The report also calls for fairer access to NHS care, with improved primary care and dentistry provision, and a national head and neck cancer cohort to facilitate research and improve understanding of the disease. The Northern Health Science Alliance recognizes the importance of tackling health inequalities and has made significant national impact through its research.

Hannah Davies, Executive Director at Health Equity North, added: “Where you live, how much money you have, and the challenges you face in daily life shouldn’t dictate your chances of surviving this cancer.” The researchers are urging policymakers to take decisive action to prevent head and neck cancer and address the long-standing inequalities that contribute to poorer outcomes in deprived communities. Further research is needed to understand the underlying drivers of these inequalities and to develop more effective prevention and early detection strategies. The NHNA is committed to continuing this work and advocating for equitable access to high-quality head and neck cancer care for all.

The report authors also suggest increased research investment is needed to develop new prevention and early-detection approaches, and to widen clinical trial participation among underserved groups. This will require a concerted effort to build trust and engagement with communities that have historically been underrepresented in research.